Id: acc3873
Group: 1sens
Protein: p65
Gene Symbol: Rela
Protein Id: P58546
Protein Name: MTPN_HUMAN
PTM: phosphorylation
Site: Ser536
Site Sequence: ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Disease Category: Cardiovascular and circulatory system diseases
Disease: Myocardial I/R Injury
Disease Subtype: diabetic
Disease Cellline:
Disease Info:
Drug: Tanshinone IIA
Drug Info: "Tanshinone IIA is a lipophilic diterpene quinone isolated from Salvia miltiorrhiza, which has various pharmacological activities such as anti - inflammatory and anti - oxidative effects."
Effect: modulate
Effect Info: The protective effect of tanshinone on myocardial ischemia/reperfusion (I/R) injury in diabetic rats by enhancing the phosphorylation of Akt and inhibiting the phosphorylation of NF–κB via the PI3K/Akt pathway.
Note:
Score: 4.0
Pubmed(PMID): 20380652
Sentence Index:
Sentence:

Sequence & Structure:

MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ

Select PDB:

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets
Small molecule
Antibody
PROTAC
Other modalities
Approved Drug
Advanced Clinical
Phase 1 Clinical
Structure with Ligand
High-Quality Ligand
High-Quality Pocket
Med-Quality Pocket
Druggable Family
Approved Drug
Advanced Clinical
Phase 1 Clinical
UniProt loc high conf
GO CC high conf
UniProt loc med conf
UniProt SigP or TMHMM
GO CC med conf
Human Protein Atlas loc
Approved Drug
Advanced Clinical
Phase 1 Clinical
Literature
UniProt Ubiquitination
Database Ubiquitination
Half-life Data
Small Molecule Binder
Approved Drug
Advanced Clinical
Phase 1 Clinical

PTM Intensity:

source: CPTAC

No data.

PTM-Disease Association:

source: PTMD

No data.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: